DNA Extraction Kit Market Analysis

DNA Extraction Kit Industry Insights

Application Analysis

• NGS is the largest category, accounting for USD 0.6 billion in 2024. It will also rise at the highest CAGR during the forecast period.
• Early diagnosis of cancer and other genetic diseases is the biggest challenge for researchers, and thus, several experiments have been conducted.
• For the diagnosis of genetic disorders, next-generation sequencing is widely used to effectively tackle this problem.
• The increasing utilization of NGS in diagnostic laboratories has improved the accuracy and consistency of genetic diagnosis. Prenatal diagnosis and predictive genetic testing are both utilizing advanced genetic diagnostic techniques.
• Therefore, the surging use of sequencing technology drives the adoption of nucleic acid isolation kits.
• This revolutionary technology has major applications after PCR, and its demand is expected to show exponential growth in the forthcoming years.

The applications analyzed here are:

• Real-Time PCR
• Cloning
• Next-Generation Sequencing (Largest and Fastest-Growing Category)
• Others

Product Analysis

• Genomic DNA is the larger category in the DNA extraction kit market.
• The extraction of genomic DNA is essential in an extensive array of areas, such as genetic research, molecular diagnostics, and forensic science.
• This has increased the demand for DNA extraction kits specific to the isolation of genomic DNA from different sample types.
• Cell-free DNA (cfDNA) is the faster-growing segment in the market, with a CAGR of 8.0%.
• This is owing to its increasing usage in non-invasive diagnostic applications, including liquid biopsies for cancer detection, prenatal testing, and post-organ transplant monitoring.
• The ability to extract cfDNA allows for the detection of biomarkers without invasive procedures, making it highly preferable in clinical settings.
• The rising popularity of liquid biopsies, coupled with precision medicine, furthers the demand for high-quality cfDNA extraction kits.

The products analyzed here are:

• Genomic DNA (Largest Category)
• Cell-Free DNA (Fastest-Growing Category)

Sample Type Analysis

• Blood, tissue, & formalin-fixed, paraffin-embedded (FFPE) is the largest category in the market, and its size is expected to reach USD 1.0 billion in 2032.
• These samples are used both for clinical diagnostics and in biobanking research; therefore, they are considered the most-essential sources for DNA extraction.
• Blood samples are widely used in genetic and disease-related studies. They and FFPE are highly essential in oncology and pathology for molecule profiling and retrospective genetic analysis.
• This rising demand for DNA extraction, primarily for cancer diagnosis and research on genetic disorders, and the shift toward preventive care models drive this category.
• Cells are the fastest-growing category due to the expanding usage of DNA in cell-based research, such as single-cell genomics and stem cell research, for drug discovery and development.
• The increase in the number of studies conducted utilizing people’s genetic codes for drug discovery and tailored therapies propels the requirement for cell-based DNA extraction kits.

The sample types evaluated here are:

• Blood, Tissue, & FFPE (Largest Category)
• Cells (Fastest-Growing Category)
• Others

End User Analysis

• Healthcare facilities the largest end users of DNA extraction kits in the market, owing to the increasing demand for early and accurate diagnosis of diseases.
• Even hereditary illnesses like sickle cell anemia, hemophilia A, and Tay-Sachs disease may be accurately diagnosed using DNA extraction procedures.
• Therefore, it is predicted that the availability of such effective technologies at moderate-to-cheap prices would increase their adoption rate in diagnostic facilities and hospitals.
• Moreover, it is expected that market expansion will be fueled by quickly adopting breakthrough technologies for the development of advanced medicines.
• The production of different medications and treatments begins with the separation and purification of nucleic acids, therefore, the use of equipment and kits needed to carry out these procedures will undoubtedly increase.
• Pharma & biotech companies are the fastest-growing category, with 9.0% CAGR.
• These companies are heavily investing in genomic research for new therapies, especially for oncology and rare diseases, where DNA analysis is required to be highly precise.
• With the growth in R&D activities by these companies to develop targeted treatments and run clinical trials, the demand for DNA extraction kits is increasing at a high rate.
• Recently, Pacific Biosciences introduced the Nanobind PanDNA kit for HiFi sequencing.
• This high-throughput extraction kit simplifies and optimizes workflows, allowing researchers to isolate high-quality DNA from intricate samples.

The end users analyzed here are:

• Healthcare Facilities (Largest Category)
• Research Institutes
• Pharma & Biotech Companies (Fastest-Growing Category)
• Others